4.6 Article

(L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky 'Forced-Traceless' Regioselective Pd-Catalyzed C(sp2)-H Activation

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Structures of the entire human opioid receptor family

Yue Wang et al.

Summary: Opioids are powerful painkillers with serious side effects. The study examines the binding and selectivity mechanisms of endogenous opioid peptides with opioid receptors, revealing a structural framework for the design of safer pain relief drugs.
Article Chemistry, Organic

Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine

Davide Illuminati et al.

Summary: A small library of NH-Boc- or NH-Fmoc-protected L-phenylalanines carrying methyl groups at positions 2 and 6 and diverse functionalities at position 4 has been synthesized through a Pd-catalyzed directed C-H dimethylation. The electronic and steric properties of the resulting amino acid derivatives can be altered by appending a variety of electron-withdrawing, electron-donating, or bulky groups.

JOURNAL OF ORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Novel Mixed NOP/Opioid Receptor Peptide Agonists

Salvatore Pacifico et al.

Summary: In this study, 31 peptides were synthesized and tested for their activity at human recombinant NOP/opioid receptors. The peptide [Dmt(1,5)]N/OFQ(1-13)-NH2 was identified as the most potent dual NOP/mu receptor agonist, with antitussive effects demonstrated in vivo. The molecular mechanisms of peptide binding to the mu receptor were elucidated through experimental and in silico studies.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemical Research Methods

Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors

Salvatore Pacifico et al.

BIOCONJUGATE CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Targeting multiple opioid receptors - improved analgesics with reduced side effects?

Thomas Guenther et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Pharmacology & Pharmacy

Pharmacological studies on the NOP and opioid receptor agonist PWT2-[ Dmt1] N/OFQ(1-13)

Maria Camilla Cerlesi et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2017)

Article Multidisciplinary Sciences

Structure-and conformationactivity studies of nociceptin/orphanin FQ receptor dimeric ligands

Salvatore Pacifico et al.

SCIENTIFIC REPORTS (2017)

Article Pharmacology & Pharmacy

In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403

Federica Ferrari et al.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)

Article Chemistry, Organic

Preparation of Constrained Unnatural Aromatic Amino Acids via Unsaturated Diketopiperazine Intermediate

Adriano Mollica et al.

JOURNAL OF HETEROCYCLIC CHEMISTRY (2016)

Article Pharmacology & Pharmacy

In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations

Federica Ferrari et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5

Remo Guerrini et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Rapid Synthesis of Boc-2′,6′-dimethyl-L-tyrosine and Derivatives and Incorporation into Opioid Peptidomimetics

Aaron M. Bender et al.

ACS MEDICINAL CHEMISTRY LETTERS (2015)

Article Pharmacology & Pharmacy

In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives

A. Rizzi et al.

BRITISH JOURNAL OF PHARMACOLOGY (2014)

Review Biochemistry & Molecular Biology

The Therapeutic Potential of Nociceptin/Orphanin FQ Receptor Agonists as Analgesics without Abuse Liability

Ann P. Lin et al.

ACS CHEMICAL NEUROSCIENCE (2013)

Article Pharmacology & Pharmacy

[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist

S. Molinari et al.

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Article Chemistry, Applied

Development of an Asymmetric Hydrogenation Route to (S)-N-Boc-2,6-dimethyltyrosine

Celine F. B. Praquin et al.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2011)

Article Biochemistry & Molecular Biology

Role of 2′,6′-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds

Gianfranco Balboni et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2010)

Article Pharmacology & Pharmacy

Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24

Carmela Fischetti et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5

Valeria Camarda et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)

Article Chemistry, Inorganic & Nuclear

A highly efficient stereocontrolled synthesis of (S)-2′,6′-dimethyltyrosine [(S)-DMT]

Daniele Balducci et al.

TETRAHEDRON-ASYMMETRY (2009)

Article Chemistry, Medicinal

Development of potent μ-opioid receptor ligands using unique tyrosine analogues of endomorphin-2

TY Li et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

Article Pharmacology & Pharmacy

2′,6′-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides

Y Sasaki et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)

Review Biochemistry & Molecular Biology

Dmt and opioid peptides: A potent alliance

SD Bryant et al.

BIOPOLYMERS (2003)

Article Biochemistry & Molecular Biology

Probing the shape of a hydrophobic pocket in the active site of δ-opioid antagonists

V Santagada et al.

JOURNAL OF PEPTIDE SCIENCE (2001)

Article Chemistry, Medicinal

Enkephalin analogues with 2′,6′-dimethylphenylalanine replacing phenylalanine in position 4

Y Sasaki et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)

Article Chemistry, Medicinal

Synthesis and in vitro opioid activity profiles of DALDA analogues

PW Schiller et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)